CD-JEV Japanese Encephalitis Vaccine Introduction
Training Modules for Health Care Workers
Module 7
Communicating about CD-JEV vaccine
with caregivers
Learning objectives
 At the end of the module, the participant will be
able to:
– Describe how to communicate with caregivers
– Advise caregivers on Japanese encephalitis
– Provide other messages to caregivers before they
leave the session
 Duration:
– 15 minutes
2 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
Key issues
1 How do I communicate with
caregivers?
2
3
How do I explain Japanese
encephalitis (JE) to caregivers?
What other messages do I
give caregivers before they
leave the immunization
session?
3 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
How do I communicate with caregivers?
 Be respectful.
 Use simple words and avoid technical terms.
 Listen to caregiver concerns.
 Make sure the caregiver has understood your key
messages.
4 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
Explaining Japanese encephalitis to caregivers
 What is Japanese encephalitis?
o Japanese encephalitis (JE) is a disabling viral disease that
affects the brain and can cause severe disability, seizures and
even death. In patients who survive the disease, 30% to 50% of
survivors suffer lifelong disability and require constant care from
family members and medical staff.
 What are the signs and symptoms of JE?
o In people who get JE, the symptoms usually begin like the flu,
with fever, chills, tiredness, headache, nausea and vomiting. The
illness can progress to a serious infection of the brain (known as
encephalitis). Many patients present with seizures or in a coma.
5 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
Explaining Japanese encephalitis to caregivers
 Who is at risk for JE?
o Anyone can get JE, but people living in rural rice-growing and pigfarming regions face increased risk. Cases are also found at the
edges of cities. In areas where JE has been present for many years,
the disease is most frequently seen in children between the ages of
1 and 15 years. Adults can also get disease.
 How is JE treated?
o There is no specific treatment for JE. However, supportive care is
important to reduce the risk of death or disability.

How can JE be prevented?
o Immunization is the best way to prevent JE; avoiding mosquito bites
is also important.
6 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
Explaining CD-JEV vaccine to caregivers
 How effective is CD-JEV?
o Studies have shown that CD-JEV protects very well against disease.
 How safe is CD-JEV?
o The CD-JEV vaccine is very safe. Most children who receive the vaccine
will not experience any side effects. However, like all vaccines, children may
experience mild symptoms such as pain or swelling at the injection site,
rash, mild fever, nausea or dizziness.
o These problems are not serious and will not last more than a few days.
o In very rare cases, there is the possibility of a severe allergic reaction.
o The parent should bring the child to a hospital or clinic as soon as possible
if a child becomes severely ill or appears to have an allergic reaction, such
as fever higher than 38.5⁰C or trouble breathing.
7 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
Key messages
 Use simple phrases and avoid technical terms to make sure the
caregiver understands your key messages.
 JE is a severe, disabling viral disease that affects the brain and can
cause severe disability, seizures and even death; it’s transmitted by
mosquitoes.
 There is no treatment for JE; the most effective and most cost-effective
prevention method is vaccination.
 CD-JEV is very safe and effective.
 Ongoing dialogue may successfully reassure vaccine-hesitant parents
that immunization is the best and safest option for their child.
8 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016
End of module
Thank you
for your attention!
 Next is Module 8: CD-JEV
immunization campaigns
9 | Communicating about CD-JEV JE vaccine with caregivers, Module 7 | 24 July 2016